Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergencyDavide Ferrari, Giovanni Guaraldi, Vittorio Iadisernia et al.|PLoS ONE|2020Cited by 80
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediatorCristina Mussini, Domenico Lo Tartaro, Alessandro Cozzi‐Lepri et al.|Clinical Microbiology and Infection|2021Cited by 22
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 PneumoniaJovana Milić, Giovanni Guaraldi, Alessio Novella et al.|AIDS Research and Human Retroviruses|2021Cited by 8
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state studyJovana Milić, Roberto D’Amico, Federico Banchelli et al.|PLoS ONE|2021Cited by 6